Abstract
Background
Acute mortality of unselected critically ill patients has improved during the last 15 years. Whether these benefits also affect survival of critically ill patients with secondary peritonitis is unclear as is the relevance of specific prognostic factors, such as source control.
Methods
We performed a retrospective analysis of data collected prospectively from March 1993 to February 2005. A cohort of 319 consecutive postoperative patients with secondary peritonitis requiring intensive care was evaluated. End points for outcome analysis were derived from daily changes of hazard rate.
Results
Four-month survival rate after intensive care unit (ICU) admission was 31.7%. For patients who have survived for more than 4 months, the 1-year survival was 82.7%. After adjustment for relevant covariates, a high disease severity at ICU admission and during ICU stay, specific comorbidities (extended malignancies, liver cirrhosis) and sources of infection (distal esophagus, stomach), and an inadequate initial antibiotic therapy were associated with worse 4-month prognosis. Inability to obtain source control was the most important determinant of mortality, and treatment after 2002 was combined with improved prognosis.
Conclusions
Four-month prognosis of critically ill, surgical patients with secondary peritonitis is poor and mostly determined by the ability to obtain source control. Outcome has improved since 2002, and after successful surgical and intensive care therapy long-term survival seems to be good.
Similar content being viewed by others
References
Anaya DA, Nathens AB (2003) Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4:355–362
Pieracci FM, Barie PS (2007) Management of severe sepsis of abdominal origin. Scand J Surg 96:184–196
Barie PS, Hydo LJ, Eachempati SR (2004) Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surg Infect (Larchmt) 5:365–373
Dellinger RP, Carlet JM, Masur H et al (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873
Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, Lauwers P (2003) Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 27:379–384
Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intra-abdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 384:24–32
McLauchlan GJ, Anderson ID, Grant IS, Fearon KC (1995) Outcome of patients with abdominal sepsis treated in an intensive care unit. Br J Surg 82:524–529
Kahn JM, Kramer AA, Rubenfeld GD (2007) Transferring critically ill patients out of hospital improves the standardized mortality ratio: a simulation study. Chest 131:68–75
Ochiai T, Hiranuma S, Takiguchi N, Ito K, Kawaguchi A, Iwai T, Arii S (2004) SOFA score predicts postoperative outcome of patients with colorectal perforation. Hepatogastroenterology 51:1007–1010
Williams TA, Dobb GJ, Finn JC, Webb SA (2005) Long-term survival from intensive care: a review. Intensive Care Med 31:1306–1315
Barie PS, Williams MD, McCollam JS, Bates BM, Qualy RL, Lowry SF, Fry DE (2004) PROWESS Surgical Evaluation Committee. Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188:212–220
Laterre PF, Levy H, Clermont G, Ball DE, Garg R, Nelson DR, Dhainaut JF, Angus DC (2004) Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Trial. Crit Care Med 32:2207–2218
Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266–2277
Billing A, Fröhlich D, Mialkowskyj O, Stokstad P, Schildberg FW (1992) [Treatment of peritonitis with staged lavage: prognostic criteria and course of treatment]. Langenbecks Arch Chir 377:305–313
Rüttinger D, Wolf H, Küchenhoff H, Jauch KW, Hartl WH (2007) Red cell transfusion: an essential factor for patient prognosis in surgical critical illness? Shock 28:165–171
Müller M, Moubarak P, Wolf H, Küchenhoff H, Jauch KW, Hartl WH (2008) Independent determinants of early death in critically ill surgical patients. Shock 30:11–16
Hartl WH, Wolf H, Schneider CP, Küchenhoff H, Jauch KW (2007) Secular trends in mortality associated with new therapeutic strategies in surgical critical illness. Am J Surg 194:535–541
Schneider CP, Wolf H, Küchenhoff H, Jauch KW, Hartl WH (2006) Trends in der chirurgischen Intensivmedizin. 12 Jahre Erfahrung an einer einzelnen Institution. Chirurg 77:700–708
Fertmann J, Wolf H, Küchenhoff H, Hofner B, Jauch KW, Hartl WH (2008) Prognostic factors in critically ill, surgical patients requiring continuous renal replacement therapy. J Nephrol (in press)
Hartl WH, Wolf H, Schneider CP, Küchenhoff H, Jauch KW (2007) Acute and long-term survival in chronically critically ill surgical patients: a retrospective observational study. Critical Care 11:R55
Lowenkron SE, Niederman MS (1992) Definition and evaluation of the resolution of nosocomial pneumonia. Semin Respir Infect 7:271–281
Nathens AB, Rotstein OD (1994) Therapeutic options in peritonitis. Surg Clin North Am 74:677–692
Wolfe RA, Strawderman RL (1996) Logical and statistical fallacies in the use of Cox regression models. Am J Kidney Dis 27:124–129
Hosmer DW, Lemeshow S (1999) Applied survival analysis. Wiley, New York, p 158
Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer-Verlag, Berlin Heidelberg, p 128
Klein JP, Moeschberger ML (2003) Survival analysis. Techniques for censored and truncated data. Springer, New York, p 295
Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York, p 84
Scheingraber S, Kurz T, Dralle H (2002) Short- and long-term outcome and health-related quality of life after severe peritonitis. World J Surg 26:667–671
Hynninen M, Wennervirta J, Leppäniemi A, Pettilä V (2008) Organ dysfunction and long-term outcome in secondary peritonitis. Langenbecks Arch Surg 393:81–86
Lamme B, Boermeester MA, Belt EJ, van Till JW, Gouma DJ, Obertop H (2004) Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg 91:1046–1054
Van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group (2007) Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298:865–872
Haraldsen P, Andersson R (2003) Quality of life, morbidity, and mortality after surgical intensive care: a follow-up study of patients treated for abdominal sepsis in the surgical intensive care unit. Eur J Surg Suppl 588:23–27
Bosscha K, Reijnders K, Jacobs MH, Post MW, Algra A, van der Werken C (2001) Quality of life after severe bacterial peritonitis and infected necrotizing pancreatitis treated with open management of the abdomen and planned re-operations. Crit Care Med 29:1539–1543
Demetriades D, Constantinou C, Salim A, Velmahos G, Rhee P, Chan L (2004) Liver cirrhosis in patients undergoing laparotomy for trauma: effect on outcomes. J Am Coll Surg 199:538–542
Farnsworth N, Fagan SP, Berger DH, Awad SS (2004) Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 188:580–583
Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH (2006) Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 34:2707–2713
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474
Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23:682–687
Sturkenboom MC, Goettsch WG, Picelli G, in ‘t Veld B, Yin DD, de Jong RB, Go PM, Herings RM (2005) Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 60:438–443
Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420
Rello J, Gallego M, Mariscal D, Soñora R, Valles J (1997) The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 156:196–200
Marshall JC, Innes M (2003) Intensive care unit management of intra-abdominal infection. Crit Care Med 31:2228–2237
Dellinger EP (1995) Intra-abdominal infections: treatment considerations. Infect Dis Clin Pract 4(Suppl 3):S163–S169
Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–652
Boos C, Kujath P, Bruch HP (2005) [Intra-abdominal mycoses]. Mycoses 48(Suppl 1):22–26
Adrie C, Azoulay E, Francais A, Clec’h C, Darques L, Schwebel C, Nakache D, Jamali S, Goldgran-Toledano D, Garrouste-Orgeas M, Timsit JF, for the OutcomeRea Study Group (2007) Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 132:1786–1793
Wichmann MW, Inthorn D, Andress HJ, Schildberg FW (2000) Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167–172
Eachempati SR, Hydo L, Barie PS (1999) Gender-based differences in outcome in patients with sepsis. Arch Surg 134:1342–1347
Fowler RA, Sabur N, Li P, Juurlink DN, Pinto R, Hladunewich MA, Adhikari NK, Sibbald WJ, Martin CM (2007) Sex-and age-based differences in the delivery and outcomes of critical care. CMAJ 177:1513–1519
Angus DC, Laterre PF, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR, PROWESS Investigators (2004) The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 32:2199–2206
Ympa YP, Sakr Y, Reinhart K, Vincent JL (2005) Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 118:827–832
Garland A (2005) Improving the ICU: part 2. Chest 127:2165–2179
Kelly WF, Eliasson AH, Stocker DJ, Hnatiuk OW (2002) Do specialists differ on do-not-resuscitate decisions? Chest 121:957–963
Acknowledgement
The authors thank D. Inthorn and H. Schneeberger for initiation and maintenance of the database.
Author information
Authors and Affiliations
Corresponding author
Additional information
C. P. Schneider and C. Seyboth contributed equally to this work.
Rights and permissions
About this article
Cite this article
Schneider, C.P., Seyboth, C., Vilsmaier, M. et al. Prognostic Factors in Critically Ill Patients Suffering from Secondary Peritonitis: A Retrospective, Observational, Survival Time Analysis. World J Surg 33, 34–43 (2009). https://doi.org/10.1007/s00268-008-9805-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-008-9805-4